Biotech Series C Investors & VC Firms

600 firms in this list, with a median first check of $1M. 112 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
BL Blindspot Ventures Management Co ADHB8 people	88🔒	Boston	US	Pre-Seed–Late Stage	—	+ Add to CRM
EX Excel Venture Management CWJERBSG8 people	88🔒	Boston	US	Seed–Late Stage	$1M – $5M	+ Add to CRM
MI Miyako Capital 三宏山哲菅常川英5 people	88🔒	Kyoto	JP	Pre-Seed–Growth	—	+ Add to CRM
HM HM Venture Partners RLDHHHPL7 people · Leads rounds	88🔒	San Francisco	US	Seed–Late Stage	—	+ Add to CRM
HI Highline Beta MDBYDBJM18 people	88🔒	Toronto	CA	Pre-Seed–Growth	—	+ Add to CRM
EI EIR Ventures AHMPSCLB10 people · Leads rounds	88🔒	Stockholm	SE	Seed–Growth	—	+ Add to CRM
SE Seiho Investment Works 関兵菅靖岡友根大7 people	88🔒	Kyoto	JP	Pre-Seed–Growth	$67K – $670K	+ Add to CRM
DO Domain Associates BDBHJBJT11 people	88🔒	Princeton	US	Seed–Growth	$200K – $15M	+ Add to CRM
CO Coinvest Capital VTEŽKJAL10 people	88🔒	Vilnius	LT	Pre-Seed–Growth	$55K – $580K	+ Add to CRM
SY Synthesis Capital CYRWSOAS13 people · Leads rounds	88🔒	London	GB	Seed–Series C	—	+ Add to CRM
BI Bios Partners LWAGADJF15 people	88🔒	Fort Worth	US	Seed–Growth	—	+ Add to CRM
NE Neulogy Ventures CMJLDSMS5 people	88🔒	Luxembourg	LU	Pre-Seed–Growth	$216K – $3.2M	+ Add to CRM
PU Pureos Bioventures DEKBMMVG11 people	88🔒	Pfäffikon	CH	Seed–Series C	—	+ Add to CRM
KU Kumpulan Modal Perdana YYLHHHLS12 people	88🔒	Petaling Jaya	MY	Seed–Late Stage	$380K – $1.5M	+ Add to CRM
CR Criteria Bio Ventures PCACSCSC8 people · Leads rounds	88🔒	Barcelona	ES	Seed–Late Stage	—	+ Add to CRM
OM Omega Funds BDCNFDMP17 people	88🔒	Boston	US	Seed–Late Stage	—	+ Add to CRM
SO Solasta Ventures MJBCDYKG8 people	88🔒	Boston	US	Seed–Series C	—	+ Add to CRM
AP APERTURE Venture Partners ANESPTTC4 people	88🔒	Boston	US	Seed–Series C	$1M – $5M	+ Add to CRM
FI Fine Structures Ventures SKAJCDDN9 people	88🔒	Cambridge	US	Pre-Seed–Late Stage	—	+ Add to CRM
PH PhotonVentures ERJDPKRG8 people	88🔒	Hilversum	NL	Pre-Seed–Late Stage	$1.1M – $2.7M	+ Add to CRM
SO Sound Bioventures CBJKAGES9 people · Leads rounds	88🔒	Malmö	SE	Seed–Late Stage	—	+ Add to CRM
IN INCE Capital PKSZSHJL8 people · Follows rounds	88🔒	Shanghai	CN	Seed–Late Stage	—	+ Add to CRM
EL Elad Gil EG1 person · Leads rounds	88🔒	San Francisco	US	Seed–Growth	$100K – $10M	+ Add to CRM
AM Amplitude Venture Capital AGBSDMJP16 people · Follows rounds	88🔒	Montreal	CA	Seed–Late Stage	—	+ Add to CRM

Blindspot Ventures Management Co

BostonPre-Seed–Late Stage

ADHB8 people

Excel Venture Management

BostonSeed–Late Stage$1M – $5M

CWJERBSG8 people

Miyako Capital

KyotoPre-Seed–Growth

三宏山哲菅常川英5 people

HM Venture Partners

San FranciscoSeed–Late Stage

RLDHHHPL7 people

Highline Beta

TorontoPre-Seed–Growth

MDBYDBJM18 people

EIR Ventures

StockholmSeed–Growth

AHMPSCLB10 people

Seiho Investment Works

KyotoPre-Seed–Growth$67K – $670K

関兵菅靖岡友根大7 people

Domain Associates

PrincetonSeed–Growth$200K – $15M

BDBHJBJT11 people

Coinvest Capital

VilniusPre-Seed–Growth$55K – $580K

VTEŽKJAL10 people

Synthesis Capital

LondonSeed–Series C

CYRWSOAS13 people

Bios Partners

Fort WorthSeed–Growth

LWAGADJF15 people

Neulogy Ventures

LuxembourgPre-Seed–Growth$216K – $3.2M

CMJLDSMS5 people

Pureos Bioventures

PfäffikonSeed–Series C

DEKBMMVG11 people

Kumpulan Modal Perdana

Petaling JayaSeed–Late Stage$380K – $1.5M

YYLHHHLS12 people

Criteria Bio Ventures

BarcelonaSeed–Late Stage

PCACSCSC8 people

Omega Funds

BostonSeed–Late Stage

BDCNFDMP17 people

Solasta Ventures

BostonSeed–Series C

MJBCDYKG8 people

APERTURE Venture Partners

BostonSeed–Series C$1M – $5M

ANESPTTC4 people

Fine Structures Ventures

CambridgePre-Seed–Late Stage

SKAJCDDN9 people

PhotonVentures

HilversumPre-Seed–Late Stage$1.1M – $2.7M

ERJDPKRG8 people

Sound Bioventures

MalmöSeed–Late Stage

CBJKAGES9 people

INCE Capital

ShanghaiSeed–Late Stage

PKSZSHJL8 people

Elad Gil

San FranciscoSeed–Growth$100K – $10M

EG1 person

Amplitude Venture Capital

MontrealSeed–Late Stage

AGBSDMJP16 people

Data sourced from public filings and firms' own websites — see our methodology.